“Your work saved my life,” Denison, now an advocate for HIV-positive women ... a three-part trial intended to evaluate various forms of PrEP (oral, injectable, and vaginal ring) in women ...

It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, and hardly a stretch for a company on the cusp of a new product cycle.

A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

PrEP is used to prevent the transmission of HIV in people who do not have the ... Missing doses of Apretude can cause it to not work as well over time. It is important not to miss or skip doses.

Eight times more young Americans are taking antiretroviral meds to protect them from HIV infection than a decade ago, a new ...

It is the first time that a PrEP trial has been shown to prevent any HIV infections from slipping through the net, according to Gilead, and showed a subcutaneous injection with lenacapavir every ...

HealthDay News — Dispensing and initiation of HIV preexposure prophylaxis (PrEP) among young adults increased from 2016 through 2023, according to a study published online May 9 in the Journal of ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

In Philippi village in the Western Cape of South Africa, 24-year-old Simamkele Matinise works at an HIV-prevention mobile ...

In a candid and heartfelt conversation with her followers, Tamar opens up about her decision to take anti-HIV PrEP (pre-exposure prophylaxis) medication. She shares that this is part of her ...

“It’s like, ‘Oh my god,’ we might have this tool that can really put an end to HIV.” Anna Katomski ... intended to evaluate various forms of PrEP (oral, injectable, and vaginal ring ...